All this grows from building a better seed.

Seed is the hero that determines all potential and resources. The opportunity for innovation within a seed through gene editing is enormous, but it has never been fully realized. However, it’s not enough to approach this new challenge with the same tools and the same thinking. It’s time to design something new.

Embracing diversity to build a more sustainable food system.

Our SEEDesign™ platform unlocks new possibilities using predictive design and advanced multiplex editing to match the diversity and complexity of nature itself. This unsurpassed technology accelerates and targets the evolutionary process for better seeds at lower cost and in less time than existing approaches.


Growth powered by technology, seeded by people.

Ambitiously grounded

We embrace challenges and are willing to take risks to deliver high impact results. We respect diverse views - seeking out and supporting ideas from others.

Collaborative innovators

We are curious explorers who believe collaboration can overcome limitations and expedite success. We bring new people together to cultivate diversity in thinking, development and execution.

Stewards of our planet

We hold ourselves accountable for the footprint that we create and strive to protect the earth for future generations.

Our Leadership Team

Inari’s leadership brings a wealth of knowledge and experience to drive the business forward through collaboration with team members at every level. They are both accessible and deeply involved - inspiring, innovating and mentoring to ensure the success of the organization well into the future.

Ponsi Trivisvavet

Ponsi Trivisvavet


Ponsi has broad and deep expertise in global agriculture as well as extensive management skill in the seeds business. Prior to joining Inari, she held a number of leadership roles at Syngenta, most recently as president of Syngenta Seeds North America. Before Syngenta, she held positions with McKinsey & Company. Ms. Trivisvavet holds an MBA from Cornell University.

Pieter Ettiene Boin

Pierre-Etienne Boin


Pierre-Etienne brings three decades of experience as an attorney specializing in international agribusiness and biotechnology law. Before joining Inari, he served as General Counsel for Seeds and Biotechnology globally at Syngenta, where he led a team of legal, intellectual property and licensing professionals. Prior to Syngenta, Pierre-Etienne worked with Novartis Seeds and Sandoz Agro. He received his law degree from University of Fribourg, Switzerland, holds a Master in European Law from Université Libre of Brussels, Belgium and graduated from the Advanced Executive Program at Northwestern University’s Kellogg School of Management. He is admitted to the Bar in Switzerland and in Massachusetts.

Stuart Brown

Stuart Brown


Stuart brings over 25 years of global experience delivering strategic transformation and growth across diverse industries. Prior to joining Inari, he served as CFO and senior finance executive at companies including Iron Mountain, Red Robin, DCT Industrial Trust, Royal Ahold, and Casper Sleep. He is a member of the National Association of Corporate Directors and has worked extensively on investor relations, capital structure and allocation, and risk management. Stuart holds a master's degree in accounting from the University of Georgia.

Nora Dutta

Nora Dutta


Nora brings over 20 years experience focused on engaging, supporting, and developing people. Before Inari, she led human resources at Corindus Vascular Robotics and was part of the leadership team that drove transformational growth, resulting in an acquisition by Siemens Healthineers. Prior to Corindus, Nora oversaw HR operations at AMAG Pharmaceuticals and served as a strategic human resources business partner at Boston Scientific. She graduated from Lehigh University with a bachelor's degree in Psychology.

Catherine Fevillet

Dr. Catherine Feuillet


Catherine brings deep experience in research innovation and extensive knowledge of genomics. Prior to Inari, she worked at Bayer CropScience, where she was head of trait research, and at the French National Institute for Agricultural Research (INRA), as research director leading the development of wheat genomics projects. Catherine is a co-founder of the International Wheat Genome Sequencing Consortium. She received her PhD from Paul Sabatier University, and served as an assistant professor at the University of Zurich, where she researched disease-resistance genes and sought a better understanding of the evolution of wheat and barley.

Michael Kock

Dr. Michael Kock


Michael brings 20 years experience creating and implementing holistic intellectual property strategies to drive innovation. Before joining Inari, Michael was head of intellectual property at Syngenta. He shaped major mergers, acquisitions, litigation, and licensing deals and was instrumental in setting up a new industry licensing platform for seeds. Prior to joining Syngenta, Michael spent 10 years with BASF. He received his PhD in Molecular Biology from Hamburg University and is a qualified European and Swiss patent attorney.

Claudia Nari

Claudia Nari

Chief Product Officer Read Bio

Claudia Nari brings 30 years of experience in the agriculture industry, with a proven record of leading diverse, international teams and deep experience in plant breeding. She comes most recently from Bayer Crop Science, where she was Head of Regulatory Science Strategy and Operations. Prior to that, she held various roles at Monsanto. Claudia began her career in soybean improvement at Nidera Sementes (now part of Syngenta), after earning a Plant Breeding degree from Universidad de Buenos Aires in Argentina.

Our Scientific Strategy Board

Comprising some of the brightest minds in modern science — their passion for our work helps unlock the full potential of our people. Through regular engagement with each of our teams, they help to set our direction – always challenging us to think bigger and bolder at every turn.

George Church

Dr. George Church


As a professor of Genetics at Harvard Medical School, George collaborates with Inari to radically change crop improvement through the application of modern genome science. His Harvard PhD research developed the first methods for direct genome sequencing, molecular multiplexing, and barcoding, which led to the first genome sequence, in 1994. George's innovations have contributed to nearly all next generation DNA sequencing methods, and his lab’s work on chip DNA synthesis, gene editing, and stem cell engineering have formed the foundation for many innovative companies. He has been elected to the National Academy of Sciences and the National Academy of Engineering.

Steve Jacobsen

Dr. Steve Jacobsen


Steve advises Inari on establishing commercial applications for technologies that regulate gene expression and modulate the epigenome to improve crop performance. He is a professor in the Department of Molecular, Cell, and Developmental Biology at the University of California at Los Angeles and serves as an investigator for the Howard Hughes Medical Institute. His lab has been instrumental in defining the mechanism of action for several gene silencing pathways in plants. Steve earned his PhD at the University of Minnesota and completed his postdoctoral studies at the California Institute of Technology. He has been elected to the National Academy of Sciences and the American Academy of Sciences.

Rodolphe Barrangov

Dr. Rodolphe Barrangou


Rodolphe helps Inari optimize CRISPR-Cas systems in crops. He is the Todd R. Klaenhammer Distinguished Professor in Probiotics Research at North Carolina State University, where he focuses on the evolution and functions of CRISPR-Cas systems and their applications in bacteria. Rodolphe has received the Warren Alpert Foundation Prize, the Canada Gairdner International Award, the NAS Award in Molecular Biology, and the NAS Prize in Food and Agriculture Sciences. He has been elected to the U.S. National Academy of Science.

Jennifer Doudna

Dr. Jennifer Doudna


Jennifer helps Inari optimize CRISPR technology for crop improvement. She shares the 2020 Nobel Prize for Chemistry for her work to identify and develop CRISPR-Cas9. Jennifer is the Li Ka Shing Chancellor's Professor in Biomedical and Health at University of California, Berkeley, and a Howard Hughes Medical Institute (HHMI) investigator. Jennifer’s lab studies many aspects of RNA biology and discovered the programmable nature of Cas nucleases. She received a Packard Foundation Fellow Award and the American Association for the Advancement of Science Fellow Award and has been elected to the National Academy of Sciences, the American Academy of Arts and Sciences, Institute of Medicine of the National Academies, and the Royal Society.

Richard Flavell

Dr. Richard Flavell


Richard served as Interim chief scientific officer (CSO) at Inari, helping the company become strategically positioned in plant science and plant breeding. His career has been associated with plant genomics, plant breeding, the development and deployment of plant transformation, and the enhancement of agricultural traits in key crops. He has also served as Director of the John Innes Centre and as CSO of Ceres, Inc. He currently serves as chair of the International Wheat Yield Partnership. His scientific accomplishments have earned him the position of Fellow of the Royal Society.

Dirk Inze

Dr. Dirk Inze


Dirk brings expertise in the development of novel solutions to major crop production challenges. He is a principal investigator and science director at VIB, a life sciences research institute in Belgium. His research aims to understand plant growth. His lab takes a systems biology approach to explore the mechanisms of leaf growth in Arabidopsis and maize, discoveries applied to improve crop productivity and response to the environment. He has been awarded the World Agriculture Prize and the Körber Stiftung Prize.

Zach Lippman

Dr. Zach Lippman


Zach brings expertise in the application of modern genome editing technology as it relateds to crop improvement. He is the Jacob Goldfield Professor of Genetics at Cold Spring Harbor Laboratory and a Howard Hughes Medical Institute investigator. A pioneer in the application of CRISPR technology to alter plant gene activity and create novel allelic variation, his research focuses on the process of flowering and flower production. He was a finalist for the Blavatnik National Awards, which honors outstanding young scientists.

Jonathan Pritchard

Dr. Jonathan Pritchard


Jonathan brings expertise in statistical and computational methods to the study of genomics and evolutionary biology. He developed STRUCTURE, a widely used computer program for determining population structure. He is a professor in the departments of genetics and biology at Stanford University. Jonathan holds Biology and Mathematics degrees from Penn State, a PhD in Biology from Stanford, and he completed post-doctoral work in Statistics at Oxford University. He was awarded the Edward Novitski Prize for creativity and intellectual ingenuity in solving significant problems in genetics research and the Mitchell Prize from the International Society for Bayesian Analysis.

Our Board

You can achieve great things when your board is passionate about the vision and mission of the organization. Our board brings experience and depth of knowledge to further enhance the talents of the team.

Michael Mack

Mike Mack


Mike was CEO of Syngenta and an executive director of the board from 2008 to 2015. Prior to Syngenta, Mike served as president of the Global Paper Division of Imerys SA, a French mining and pigments company. Mike has also held various roles with Mead Corp. and served as chairman and president of the board of the Swiss-American Chamber of Commerce. Mike has a degree in Economics from Kalamazoo College, studied at the University of Strasbourg, and holds an MBA from Harvard University.

Bob Bechek

Bob Bechek


Bob is a partner and former worldwide managing director (CEO) and board chair of consulting firm Bain & Company, where he's held a number of leadership and governance roles across his 32 years with the organization. Prior to joining Bain, Bob led mechanical research and development for AKR Robotics in Paris, France. He later founded the U.S. subsidiary, as vice president and general manager. Bob received his MBA from Harvard University and a bachelor's degree in Mechanical Engineering from the Massachusetts Institute of Technology.

Robert Berendes

Dr. Robert Berendes


Robert is a venture partner at Flagship Pioneering and chairman of Indigo Ag and CiBO Technologies. He co-owns and serves as a partner of a-connect, a global talent management firm, where he leads their agribusiness, food, and chemicals practice. He is also an operating director at Paine Schwartz Partners and serves on the boards of Verdesian Life Sciences and AgBiTech. Previously, he served as Syngenta’s Global head of business development and member of its executive committee. Robert has a PhD in Biophysics from the Max Planck Institute for Biochemistry and Technical University of Munich and a diploma in Chemistry from the University of Cologne.

Howard W Buffett

Howard W. Buffett


Howard is a professor at Columbia University with research focused on social and sustainability-related impact measurement and analysis. Previously, he was executive director of the Howard G. Buffett Foundation, which strengthens food security for vulnerable populations throughout the world. He also oversaw agricultural economic redevelopment and stability programs in Afghanistan and Iraq for the U.S. Department of Defense, and was a policy advisor for the White House Domestic Policy Council. He is on boards for Case New Holland Industrial (NYSE:CNHI), Toyota (NYSE:TM), REEF Technology, and S2G Ventures.

Ignacio Martinez

Ignacio Martinez


Ignacio was founding CEO of Inari as well as a general partner of Flagship Pioneering. Ignacio joined Flagship to lead its sustainability activities in addition to entrepreneurial activities in life sciences, with a special interest on food, nutrition, and health. Ignacio is co-founder and founding CEO of CiBO Technologies, Inari Agriculture, Invaio Sciences, Senda Biosciences, Montai Health and founding director at Indigo Agriculture. Prior to joining Flagship, Ignacio was a managing director of Syngenta Ventures. He holds an International MBA from Instituto de Empresain Spain and WHU Otto Beisheim School of Management in Germany.

Rob Rosiello

Rob Rosiello


Rob is executive partner and chief operating officer at Flagship Pioneering, where he oversees all aspects of Flagship’s processes for originating and developing new companies. Previously, Rob worked for 30 years at McKinsey & Company as a senior partner advising the CEOs and boards of leading health care, technology, and consumer companies. He currently serves on the board and executive committee of Catholic Charities of New York and the Central Selection Committee of the Morehead-Cain Foundation at the University of North Carolina. Rob earned his MS in Economics from the London School of Economics and an MBA from Harvard University.

Ponsi Trivisvavet

Ponsi Trivisvavet


Ponsi has broad and deep expertise in global agriculture as well as extensive management skill in the seeds business. Prior to joining Inari, she held a number of leadership roles at Syngenta, most recently as president of Syngenta Seeds North America. Before Syngenta, she held positions with McKinsey & Company. Ms. Trivisvavet holds an MBA from Cornell University.

Join Us.

We are driven by our mission to transform the global food system for the benefit of farmers, society and the planet. If you want to challenge the status quo within our bold, diverse culture, join us - and find out how you can help grow tomorrow with Inari.